This Article Abstract Full Text (PDF) Other Versions of this Article: JVI.02333-06v1 81/8/3949    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sadagopan, S. Articles by Chandran, B. Search for Related Content PubMed PubMed Citation Articles by Sadagopan, S. Articles by Chandran, B.

Kaposi's Sarcoma-Associated Herpesvirus Induces Sustained NF-B Activation during De Novo Infection of Primary Human Dermal Microvascular Endothelial Cells That Is Essential for Viral Gene Expression

Department of Microbiology and Immunology, H. M. Bligh Cancer Research Laboratories, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois

Received 24 October 2006/ Accepted 24 January 2007

	ABSTRACT

Top Abstract Introduction Materials and Methods Results Discussion References

 
In vitro Kaposi's sarcoma-associated herpesvirus (KSHV) infection of primary human dermal microvascular endothelial (HMVEC-d) cells and human foreskin fibroblast (HFF) cells is characterized by the induction of preexisting host signal cascades, sustained expression of latency-associated genes, transient expression of a limited number of lytic genes, and induction of several cytokines, growth factors, and angiogenic factors. Since NF-B is a key molecule involved in the regulation of several of these factors, here, we examined NF-B induction during de novo infection of HMVEC-d and HFF cells. Activation of NF-B was observed as early as 5 to 15 min postinfection by KSHV, and translocation of p65-NF-B into nuclei was detected by immunofluorescence assay, electrophoretic mobility shift assay, and p65 enzyme-linked immunosorbent assay. IB phosphorylation inhibitor (Bay11-7082) reduced this activation significantly. A sustained moderate level of NF-B induction was seen during the observed 72 h of in vitro KSHV latency. In contrast, high levels of ERK1/2 activation at earlier time points and a moderate level of activation at later times were observed. p38 mitogen-activated protein kinase was activated only at later time points, and AKT was activated in a cyclic manner. Studies with UV-inactivated KSHV suggested a role for virus entry stages in NF-B induction and a requirement for KSHV viral gene expression in sustained induction. Inhibition of NF-B did not affect target cell entry by KSHV but significantly reduced the expression of viral latent open reading frame 73 and lytic genes. KSHV infection induced the activation of several host transcription factors, including AP-1 family members, as well as several cytokines, growth factors, and angiogenic factors, which were significantly affected by NF-B inhibition. These results suggest that during de novo infection, KSHV induces sustained levels of NF-B to regulate viral and host cell genes and thus possibly regulates the establishment of latent infection.

	INTRODUCTION

Top Abstract Introduction Materials and Methods Results Discussion References

 
Kaposi's sarcoma (KS) is a chronic inflammation-associated malignancy characterized by spindle-shaped endothelial cells, inflammatory cells, growth factors, and cytokines. KS is an AIDS-defining vascular tumor, and in the absence of human immunodeficiency virus type 1 infection, KS occurs in three distinct epidemiologic forms, the classic KS, endemic-aggressive KS, and transplantation-associated KS. Chang et al. (12) reported the identification of a novel herpesvirus DNA sequence, KS-associated herpesvirus (KSHV) (also called human herpesvirus 8), in all four types of KS lesions, suggesting a potential common etiological factor for KS. KSHV is also etiologically associated with two lymphoproliferative disorders, namely, body cavity-based B-cell lymphoma (BCBL) and primary effusion lymphoma (PEL) (11), and some forms of multicentric Castleman's disease. BCBL cell lines, such as BCBL-1 and BC-3, carry KSHV in a latent form, and a lytic cycle can be induced by chemical agents (56).

KSHV DNA and transcripts have been detected in B cells from the peripheral blood, B cells in BCBL and multicentric Castleman's disease, flat endothelial cells lining the vascular spaces of KS lesions, typical KS spindle cells, CD45⁺/CD68⁺ monocytes in KS lesions, keratinocytes, and epithelial cells (15, 17, 43). KSHV DNA is present in a latent form in the vascular endothelial and spindle cells of KS tissues, and expression of latency-associated LANA-1 (open reading frame [ORF] 73), v-cyclin D (ORF 72), v-FLIP (K13), and kaposin (K12) genes has been demonstrated in these cells (15, 17, 56, 63, 78). Lytic infection has also been detected in KS lesions, with <1% of infiltrating inflammatory monocytic cells positive for lytic cycle proteins (15, 17). In addition, KSHV lytic cycle K5 gene expression has been also detected in the endothelial cells and spindle cells of KS tumors (30, 65).

KSHV infects a variety of in vitro target cells, such as human B, endothelial, and epithelial cells and fibroblasts (1, 2). We have previously demonstrated that within 5 min postinfection (p.i.) of adherent target cells, KSHV induced the preexisting host cell signal pathways, such as FAK, Src, phosphatidylinositol 3-kinase (PI 3-K), Rho GTPases, PKC, MEK1/2, and ERK1/2 (44, 57, 58). In contrast to alpha- and betaherpesviruses, in vitro infection by KSHV does not result in a productive lytic cycle. Instead, KSHV infection of primary human dermal microvascular endothelial (HMVEC-d) cells and human foreskin fibroblasts (HFF) is characterized by the sustained expression of latency-associated ORFs 73, 72, and K13. A unique aspect of this in vitro infection is our demonstration of the concurrent expression of a limited set of lytic cycle genes with antiapoptotic and immune modulation functions, including the lytic cycle switch ORF 50, or the RTA gene (30). While the expression of latent ORF 72, 73, and K13 genes continued, that of nearly all lytic genes declined (7, 30). Further examination revealed a steady quantitative increase in early lytic K5, K8, and v-IRF2 gene expression (57). KSHV-K5 gene expression persisted throughout the 5-day period of observation (30), and down regulation of major histocompatibility complex classes IA and -C, ICAM-1, CD31/PECAM, and B7-2 molecules could be detected for up to 5 days in the infected HMVEC-d cells (14, 20, 70). Similar to our observation, very early ORF 50 expression and subsequent decline were also seen during primary KSHV infection of human 293 cells (36). Bechtel et al. (7) showed that 10 of the 29 RNA transcripts detected in our system coding ORFs, such as K8.1, K12, ORF 58/59, and ORF 54, were present in the purified virion particles. However, other transcripts detected by us were absent, suggesting de novo transcription of the remaining lytic genes during the initial hours of infection. The characteristic expression of limited lytic cycle genes could be a "strategy" that allows KSHV to evade the immune system and to provide necessary factors and time to establish and/or maintain latency during the initial phases of infection. Establishment of latent infection by KSHV thus provides a good in vitro model for studying viral and host factors involved in the establishment and maintenance of latent infection. How KSHV achieves selective activation of RTA-responsive genes without initiating the full lytic cascade is a challenge to the understanding of KSHV latency. The newly synthesized ORF 73 protein can potentially influence the functions of ORF 50, since LANA-1 has been shown to counter the transactivation of certain lytic promoters by RTA. However, this may not be fully effective at early times during primary infection in the presence of abundant RTA (30). Our hypothesis is that KSHV-induced signal cascades and host cell reprogramming induced during primary infection may play important roles in the establishment of latent infection and in suppression of the lytic cycle.

As an initial step toward understanding how KSHV establishes in vitro latent infection, we have previously examined the modulation of host cell gene expression at 2 and 4 h p.i. of primary HMVEC-d and HFF cells using oligonucleotide arrays (46). We observed the reprogramming of host transcription regulating apoptosis, cell cycle regulation, signaling, inflammatory response, and angiogenesis (46). Notable among these was the strong induction of several proinflammatory cytokines and growth factors (46). Since several of these factors could be induced by NF-B, here, we examined the induction of NF-B early during target cell infection and its role in KSHV infection.

NF-B belongs to a highly conserved family of transcription factors with an N-terminal Rel homology domain and a C-terminal transactivation domain that includes c-Rel, p50 (NF-B₁), p52 (NF-B₂), p65 (RelA), and RelB (5, 6, 21). Each of these polypeptides can form homodimers or dimerize with other Rel family members, and the prototype NF-B is composed of p50 and p65. The function of NF-B is regulated by a series of inhibitory molecules named IBs. IB molecules sequester NF-B in the cytoplasm, thus rendering it inactive. Posttranslational modifications of IB, induced by various stimuli or viral infections that activate different signal transduction pathways, result in the activation of IB and subsequent proteolytic degradation. This causes the release of NF-B, which translocates to the nucleus and transcribes NF-B-dependent target genes. In lymphocytes, the IB proteins are unstable, and high levels of NF-B are constitutively present in the nucleus (42). In B-lymphoma cells latently infected with human gammaherpesviruses, like Epstein-Barr virus and KSHV, NF-B activity is further elevated by the expression of latent viral gene products that activate the NF-B signaling pathway (13, 19, 32). In Epstein-Barr virus and KSHV infections, the latency-associated proteins, like LMP1 and vFLIP, respectively, have been shown to be responsible for the sustained activation of NF-B (69, 76). Blocking NF-B is known to disturb latency and down regulate NF-B-inducible cytokines, resulting in apoptosis (28, 64). However, the role played by NF-B during primary infection of endothelial cells has not been studied.

In this study, we examined the induction of NF-B during KSHV de novo infection of primary HMVEC-d cells and HFF and present a comprehensive view of NF-B and the other factors induced during early and late stages of infection. We demonstrate that KSHV binding to target cells resulted in early induction of NF-B, which was maintained at a sustained moderate level throughout the 72-h period of observation, and activated NF-B via the AP-1 family of transcription factors playing a role in the regulation of viral and host genes, such as those encoding cytokines and growth factors.

	MATERIALS AND METHODS

Top Abstract Introduction Materials and Methods Results Discussion References

 
Cells. HFF (Clonetics, Walkersville, MD) were grown in Dulbecco's modified Eagle's medium (Gibco BRL, Grand Island, NY) supplemented with 10% heat-inactivated fetal bovine serum (HyClone, Logan, UT), 2 mM L-glutamine, and antibiotics. HMVEC-d cells (CC-2543; Clonetics) were maintained in endothelial basal medium 2 (EBM-2) in the presence of necessary growth factors (Clonetics). The cells were maintained in 5% CO₂ at 37°C. KSHV carrying BCBL-1 cells were cultured in RPMI 1640 (Gibco BRL, Grand Island, NY) medium with 10% heat-inactivated fetal bovine serum, L-glutamine, and antibiotics (44). Recombinant green fluorescent protein-KSHV (GFP-KSHV.152)-carrying BCBL-1 cells (71) were cultured in RPMI 1640 (Gibco BRL) medium (44).

Antibodies, substrates, and chemicals. Chemicals of the highest purity available were purchased. Rabbit antibodies detecting the phosphorylated forms of ERK1/2 (Thr 202/Tyr 204 phospho-p44/42 mitogen-activated protein kinase [MAPK]), p38 MAPK (Thr180/Tyr182 phospho-p38 MAPK), AKT, anti-mouse phospho-p65, total p65, total AKT, total p38 antibodies, and U0126 (1,4-diamino-2,3-dicyano-1,4-bis-[2-amino phenylthio] butadiene) were from Cell Signaling Technology, Beverly, MA. Total ERK2 antibody was from Santa Cruz Biotechnology Inc., Santa Cruz, CA. LY294002 [20(4-morphodinyl)-8-phenyl-1(4H)-benzopyran-4-one], Bay11-7082 [(E)-3-(4-methylphenylsulfonyl)-2-propenenitrile], heparin, and antibodies to ß-tubulin and ß-actin (clone AC-40) were obtained from Sigma, St. Louis, MO. Anti-rabbit and anti-mouse horseradish peroxidase- or alkaline phosphatase-linked antibodies were from Kirkegaard & Perry Laboratories, Inc., Gaithersberg, MD. Secondary antibodies for immunofluorescence were purchased from Molecular Probes-Invitrogen Corp., Carlsbad, CA.

Virus. The KSHV lytic cycle was induced in BCBL-1 cells, and virus from the supernatants was purified according to procedures described previously (44). Briefly, BCBL-1 cells were stimulated with 20 ng/ml of tetradecanoyl phorbol acetate (Sigma) for 6 days, and virus in the spent culture medium was concentrated and DNase treated. UV inactivation of virus was done to prepare replication-defective KSHV by inactivating the KSHV with UV light (365 nm) for 20 min at a 10-cm distance (UV-KSHV), followed by DNase treatment (57). DNA was extracted from live KSHV and UV-KSHV, and viral DNA copy numbers were quantified by real-time DNA PCR using primers amplifying the KSHV ORF 73 gene (30).

Cytotoxicity assay. Target cells were tested for their viability at various time points post-serum starvation and in the presence of various concentrations of Bay11-7082 at 37°C for different times (58, 73). EBM-2 and Dulbecco's modified Eagle's medium containing different concentrations of various inhibitors were incubated with HMVEC-d cells for 4 h. At different time points, supernatants were collected and assessed for cellular toxicity using an lactate dehydrogenase cytotoxicity assay kit (Promega, Madison, WI). The percent viabilities of HMVEC-d cells after 8 h, 24 h, 36 h, and 48 h of serum starvation were 93%, 91%, 84%, and 81%, respectively. The viabilities of cells after 4 h of incubation with 2 µM, 5 µM, 10 µM, 15 µM, 20 µM, 25 µM, 30 µM, 35 µM, and 40 µM concentrations of Bay11-7082 were 87%, 79%, 78%, 65%, 56%, 51%, 38%, 37%, and 35%, respectively.

Western blotting. Target cells grown to confluence in 25-cm² flasks were serum starved and induced with KSHV (multiplicity of infection [MOI], 10, or 10 DNA copies/cell) at 37°C. For inhibitor studies, the cells were exposed to NF-B inhibitor (Bay11-7082) for 1 h at 37°C prior to KSHV infection. After treatment, the cells were washed twice with phosphate-buffered saline (PBS), pH 7.4, and total protein was extracted. Total cell lysates (10 µg) were resolved on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels, transferred to nitrocellulose membranes, and immunoblotted with antibodies. Immunoreactive bands were developed by enhanced chemiluminescence reaction (NEN Life Sciences Products, Boston, MA) and quantified following standard protocols (58).

Immunofluorescence assay. HMVEC-d cells and HFF grown in eight-well chamber slides (75% confluence) (Nalge Nunc International, Naperville, IL) were serum starved, Bay11-7082 pretreated or left untreated, and incubated with KSHV for 20 min and 10 min, respectively. For colocalization studies, HMVEC-d cells were infected with KSHV for 2 h in serum-free EBM-2, followed by the addition of EBM-2 with serum and growth factors, and incubated for an additional 46 h. GFP-KSHV infection was done according to procedures described previously (59). At appropriate time points, the cells were washed with PBS, fixed with 3.7% paraformaldehyde for 10 min at room temperature, permeabilized for 10 min with 0.1% Triton X-100, and blocked for 45 min with 5% bovine serum albumin in PBS. The cells were incubated with a 1:500 dilution of rabbit anti-p65 antibody or anti-LANA antibody for 1 h at room temperature, followed by incubation with goat anti-rabbit antibody labeled with Alexa Fluor 488 (Molecular Probes-Invitrogen Corp.). After being washed with PBS, the cells were mounted with antifade reagent containing DAPI (4,6-diamidino-2-phenylindole) and observed under a fluorescence microscope equipped with the Nikon Metamorph digital imaging system 7.

Nuclear-extract preparation. HMVEC-d and HFF cells were left untreated or pretreated with Bay11-7082 at 37°C for 1 h and infected with KSHV (10 DNA copies/cell) for 15 min, 30 min, and 60 min. Nuclear extracts were prepared using a Nuclear Extract Kit (Active Motif Corp, Carlsbad, CA) according to the manufacturer's instructions. After protein concentrations were measured with bicinchoninic acid protein assay reagent (Pierce Biotechnology, Rockford, IL), the extracts were stored at –70°C. The purity of the nuclear extracts was assessed by immunoblotting using anti-lamin B antibodies, and cytoskeletal contamination was checked for by using anti-ß-actin and anti-ß-tubulin antibodies.

NF-B DNA binding assay. Five micrograms of Bay11-7082-pretreated and untreated nuclear extracts was assayed for activated NF-B by an enzyme-linked immunosorbent assay (ELISA)-based assay kit (Active Motif). This assay, which has been reported to be more sensitive than the gel shift assay, uses 96-well plates coated with oligonucleotides containing the NF-B consensus sequence (5'-GGGACTTTCC-3'). Excess (40 pmol) mutant probe (5'-AGTTGAGGCCATTTCCCAGGC-3') and wild-type (wt) probe (5'-AGTTGAGGGGACTTTCCCAGGC-3') were added to reactions in the competition experiments. Plates were washed three times in wash buffer (PBS, 0.1% Tween 20), incubated with a horseradish peroxidase-conjugated anti-rabbit immunoglobulin G antibody for 1 h, washed three times, and incubated with 100 µl of developing solution for 2 to 5 min, followed by the addition of 100 µl stop solution according to the manufacturer's instructions. Plates were read with an ELISA plate reader at 450 nm with a reference wavelength of 655 nm.

EMSA. The B and Oct1 consensus oligonucleotides were obtained from Santa Cruz Biotechnology, Inc. The double-stranded oligonucleotides were labeled at the 5' end with [-³²P]ATP (Perkin-Elmer) using T4 polynucleotide kinase (Gibco BRL). Binding reaction mixtures were incubated on ice for 20 min, and reactions were performed in 20 µl reaction volumes containing 50 mmol/liter NaCl, 10 mmol/liter Tris-HCl, pH 7.5, 1 mmol/liter MgCl₂, 0.5 mmol/liter EDTA, 0.5 mmol/liter dithiothreitol, 9% (vol/vol) glycerol, 1 µg poly(dI-dC), 5 µg nuclear extract, and labeled probe (10,000 cpm). The resulting DNA-protein complexes were then size fractionated from the free DNA probe by electrophoresis at 200 V on a 5% native polyacrylamide gel. The gel was dried at 80°C and autoradiographed. A competition electrophoretic mobility shift assay (EMSA) was performed by adding a 100x molar excess of unlabeled double-stranded B oligonucleotide probe. The nucleotide sequences of the annealed DNA probes used for B consensus and Oct1 consensus were as follows: B consensus, 5'-AGTTGAGGGGACTTTCCCAGGC-3', and Oct1 consensus, 5'-TGTGGAATGCAAATCACTAGAA-3'.

Measurement of KSHV internalization by real-time DNA PCR. Target cells that were left untreated or were treated with inhibitor were infected with KSHV at 10 DNA copies/cell. After 2 h of incubation, the cells were washed twice with PBS to remove the unbound virus, treated with trypsin-EDTA for 5 min at 37°C to remove the bound but noninternalized virus, and washed, and the total DNA was isolated using a DNeasy kit (QIAGEN, Valencia, CA). A total of 100 ng of DNA samples, KSHV-ORF 73 gene TaqMan probe (30), gene-specific primers, and Quantitect PCR mixture was used. The KSHV ORF 73 gene, cloned in the pGEM-T vector (Promega), was used for the external standard. Known amounts of ORF 73 plasmid were used in the amplification reactions, along with the test samples. The lower limit of ORF 73 gene detection was 10 to 100 copies, and the most accurate detection was from 100 to 10⁶ copies. The cycle threshold values were used to plot the standard graph and to calculate the relative copy numbers of viral DNA in the samples.

Real-time RT-PCR. KSHV-infected cells, untreated or pretreated with Bay11-7082 prior to infection, were washed twice with 1x PBS to remove the unbound virus and lysed with RLT buffer (QIAGEN), and the monolayer was scraped to collect the lysate. Total RNA was isolated from the lysate (15 min, 30 min, 60 min, 90 min, 2 h, 8 h, and 24 h p.i.) using RNeasy kits (QIAGEN) according to the manufacturer's protocols, quantified spectrophotometrically, and stored at –80°C. The ORF 50, ORF 73, K5, K8, and v-IRF2 transcripts were detected by real-time reverse transcription (RT)-PCR using specific real-time primers and specific TaqMan probes as described previously (57). The expression levels of the viral transcripts were normalized to GAPDH (glyceraldehyde-3-phosphate dehydrogenase) gene expression.

Transcription factor activation assay. Five micrograms of each nuclear extract was used for the transcription factor activation assay. Transcription factors FosB, cFos, Fra1, Fra2, phospho-c-Jun, JunB, and JunD in the nuclear extracts were measured using the ELISA-based TransAM AP-1 Family kit (Active Motif Corp.) according to the manufacturer's instructions. In this assay, transcription factors bind to the immobilized oligonucleotide containing the consensus sequences specific for the particular transcription factor, which is then detected by a sandwich ELISA. The active form of the transcription factor contained in the nuclear extract specifically binds to this oligonucleotide mixture. The primary antibodies used to detect each of the AP-1 transcription factors recognize an epitope in the phosphorylated-c-Jun, JunB, JunD, cFos, FosB, Fra1, and Fra2 that is accessible only when these transcription factors are activated and bound to their target DNAs. The detection limit for the TransAM AP-1 Family kit is <0.5 µg nuclear extract/well. Competition assays were done by premixing nuclear extracts for 30 min at 4°C with wt and mutated consensus oligonucleotides provided in the kit before adding them to the probe immobilized on the plate.

Cytokine array. Conditioned media obtained by centrifuging serum-starved, untreated, or NF-B inhibitor (Bay11-7082)-pretreated HMVEC-d cells infected with KSHV (50 DNA copies/cell) were used to study the cytokine profile using a human protein cytokine array kit from Ray Biotech (Norcross, GA). Uninfected HMVEC-d cells were used as a control. The cytokine detection membranes were blocked with a blocking buffer for 1 h at room temperature and then incubated with conditioned media at 4°C overnight. The membranes were washed, incubated with 1 ml of primary biotin-conjugated antibody at room temperature for 2 h, and subsequently washed, incubated with 2 ml of horseradish peroxidase-conjugated streptavidin at room temperature for 30 min, developed by using enhanced-chemiluminescence-type solution, exposed to film, and processed by autoradiography. Signal intensities were quantitated using an Alpha Inotech Image analysis system. All of the arrays were normalized to the same background levels with positive and negative substrate controls using the software Ray Bio Human Antibody Array 5.1 Analysis Tool.

	RESULTS

Top Abstract Introduction Materials and Methods Results Discussion References

 
KSHV induces the activation of NF-B early during infection of HMVEC-d and HFF cells. In a normal resting cell, NF-B is sequestered in the cytoplasm due to its association with a family of inhibitory proteins called IB. A variety of external stimuli, like viral infections, growth factors, and cytokines, are known to phosphorylate IB through the IKK complex, leading to the activation of NF-B. Treatment of HMVEC-d cells and HFF with 20 ng/ml tumor necrosis factor alpha (TNF-), a known stimulator of the NF-B pathway, for 20 min showed about threefold increase in the phosphorylation levels of p65 and IB (Fig. 1A and C, lane 7; Fig. 1B, lane 1).

View larger version (40K): [in this window] [in a new window]   FIG. 1. (A, B, and C) Detection of activated NF-B in KSHV-infected HMVEC-d cells and HFF. HMVEC-d cells (A) and HFF (B) grown to 80% confluence were serum starved and infected with KSHV (10 DNA copies/cell), and p65 protein phosphorylation was monitored at the indicated time points. The cells were washed and lysed with RIPA lysis buffer, and the lysates were adjusted to equal amounts of protein, resolved on SDS-10% PAGE, and transferred to nitrocellulose membranes. The membranes were immunoblotted with monoclonal antibodies against phospho-p65 protein (top), total p65 protein (middle), or ß-actin (bottom). (C) HFF that were either uninfected or infected with KSHV (10 DNA copies/cell) at various time points were Western blotted using phospho-IB (top), total IB (middle), and ß-actin (bottom) antibodies. The level of phosphorylated p65 in uninfected cells was considered to be 1 for comparison. (D, E, and F) Specificity of NF-B induction by KSHV and inhibition by Bay11-7082. Serum-starved HMVEC-d cells (D) and HFF (E and F), untreated or pretreated with 5, 10, or 20 µM Bay11-7082 (lanes 3, 4, and 5, respectively), were either uninfected (lane 1) or infected with 10 DNA copies/cell of KSHV for 15 min. For a control, serum-starved cells were infected for 30 min with virus preincubated with 100 µg/ml of heparin for 60 min at 37°C (lane 6). The cell lysates were reacted in Western blot reactions with anti-phospho-p65 antibodies (top). The membranes were stripped and reprobed with anti-p65 antibodies (middle) and ß-actin antibodies (bottom). NF-B induction with virus alone was considered 100%, and the data are presented as the percent inhibition of p65 phosphorylation. (F) Bay11-7082-pretreated HFF lysates were immunoblotted with phospho-ERK1/2 antibodies (top, lanes 1 to 5). ERK1/2 phosphorylation in virus-infected cells was measured in the presence of the MAPK inhibitor U0126 (top, lane 6). The blots were stripped and reprobed for total ERK2 (middle) and ß-actin (bottom) levels. Each blot is representative of at least three independent experiments, and percent inhibition was calculated with respect to the phosphorylated levels of p65 in KSHV-infected cells without Bay11-7082 pretreatment.

Specificity of KSHV-induced NF-B activation in HMVEC-d and HFF cells. Bay11-7082 is an inhibitor of IB phosphorylation and is known to inhibit NF-B activation (8). To determine whether abrogation of IB phosphorylation could inhibit KSHV-induced NF-B activation, cells pretreated with various concentrations of Bay11-7082 were infected with KSHV for 15 min and then analyzed for NF-B activation. We observed a dose-dependent inhibition of KSHV-induced p65 activation by Bay11-7082 in infected HMVEC-d cells and HFF (Fig. 1D and E, top, lanes 3 to 5).

KSHV binds to the adherent target cell surface heparan sulfate via its envelope glycoproteins gB and gpK8.1A (1, 72). Blocking this interaction with heparin, an analogue of heparan sulfate, prevents KSHV binding to the target cells and infection (2, 72). To demonstrate whether NF-B activation was due to KSHV binding and entry into the target cell and not due to contaminating materials or lipopolysaccharide, cells were infected for 30 min with KSHV preincubated with heparin, and lysates were analyzed for NF-B-p65 phosphorylation. Heparin treatment blocked the KSHV-induced NF-B activation by about 81% and 77% in HMVEC-d cells and HFF, respectively (Fig. 1D and E, top, lane 6), indicating that NF-B activation was indeed due to KSHV infection.

We had previously shown that KSHV infection induces a rapid transient MEK1/2 and ERK1/2 phosphorylation in HMVEC-d cells and HFF (57). When lysates from Bay11-7082-pretreated cells were tested with phospho-ERK1/2 antibodies, Bay11-7082 pretreatment had no effect on KSHV-induced ERK1/2 phosphorylation (Fig. 1F, top, lanes 3 to 5). In contrast, pretreatment of cells with 10 µM U0126, a MEK1/2-specific inhibitor, resulted in about 82% inhibition of KSHV-induced ERK1/2 phosphorylation (Fig. 1F, top, lane 6). There was no change in the total ERK2 levels (Fig. 1F, middle, lanes 1 to 6). Equal loading was confirmed using anti-ß-actin antibodies (Fig. 1F, bottom, lanes 1 to 6). These results demonstrated the specificity of inhibition by Bay11-7082 pretreatment, as well as the specificity of KSHV-induced NF-B activity.

KSHV triggers the rapid nuclear translocation of activated NF-B-p65. Once activated in a stimulus-specific manner, NF-B rapidly translocates into the nucleus and induces the transcription of various cellular genes (48). Since KSHV induced the NF-B early during infection, we examined the uninfected and infected cells by immunofluorescence assay using polyclonal antibody against NF-B-p65. Rapid nuclear translocation of p65 in >90% of KSHV-infected HMVEC-d cells (Fig. 2C and D) and HFF (Fig. 2I and J) was observed 20 min and 10 min p.i., respectively. In contrast NF-B-p65 was predominantly localized in the cytoplasm of uninfected cells (Fig. 2A, B, G, and H). Pretreatment with Bay11-7082 significantly inhibited nuclear translocation in both HMVEC-d cells (Fig. 2E and F) and HFF (Fig. 2K and L). These results confirmed the specificity of NF-B induction and further supported our observation that KSHV induces NF-B early during infection of target cells.

View larger version (55K): [in this window] [in a new window]   FIG. 2. Nuclear translocation of NF-B-p65 in KSHV-infected cells. Serum-starved HMVEC-d cells and HFF grown in eight-well chamber slides were infected with KSHV (10 DNA copies/cell) for 20 min and 10 min, respectively; washed; fixed; permeabilized; and stained with anti-p65 polyclonal antibody. HMVEC-d cells and HFF were either uninfected (A, B, G, and H) or infected with KSHV (10 DNA copies/cell) (C, D, I, and J) or incubated with 10 µM Bay11-7082, followed by infection with KSHV (E, F, K, and L), and stained for NF-B-p65. DAPI was used as a nuclear stain and merged with p65 staining.

View larger version (23K): [in this window] [in a new window]   FIG. 3. Colocalization of NF-B-p65 and ORF-73 (LANA-1) in KSHV-infected HMVEC-d cells. (A) Serum-starved HMVEC-d cells grown in eight-well chamber slides were infected with KSHV (10 DNA copies/cell) for 48 h, washed, fixed, permeabilized, and stained with anti-p65 polyclonal antibody. (B) Merged image of DAPI-stained nuclei with p65 staining. (C) HMVEC-d cells infected with GFP-KSHV for 48 h. (D) Merged image of DAPI-stained nuclei with GFP staining. (E to L) Colocalization of LANA-1 and p65. LANA (green in panels E and I) and p65 (red in panels F and J) in uninfected (E to H) and infected (I to L) HMVEC-d cells. (G and K) DAPI staining merged with LANA-1 and p65 (H and L). The arrows (A) indicate p65 nuclear staining, and the arrowheads (L) indicate cells positive for LANA-1 and p65 nuclear staining.

View larger version (41K): [in this window] [in a new window]   FIG. 9. Up regulation of proinflammatory cytokines, growth factors, angiogenic factors, and chemokines in HMVEC-d cells by KSHV. Densitometric analysis of cytokine array blots was carried out to determine the difference in the release of human cytokines from serum-starved, untreated HMVEC-d cells and KSHV-infected cells at three different time points. The values were normalized to identical background levels using the Ray Bio Human Cytokine antibody array V analysis tool. The increases in the cytokine levels were calculated by dividing the respective values obtained from infected-cell supernatants with the values obtained from uninfected-cell supernatants and cytokines showing significant change represented in a line graph format. (A) Proinflammatory cytokines, (B) growth factors, (C) angiogenic factors, and (D) chemokines that showed significant changes with respect to uninfected cells are represented in the graph.

KSHV infection increases the NF-B DNA binding activity in HMVEC-d and HFF cells.

View larger version (34K): [in this window] [in a new window]   FIG. 4. Detection of KSHV-induced nuclear translocation of NF-B-p65 by ELISA. (A) Nuclear extracts from HMVEC-d cells and HFF infected with KSHV (10 DNA copies/cell) for 30 min were prepared and assayed for NF-B DNA binding activity by ELISA. Plates immobilized with oligonucleotides specific for the B site were incubated with nuclear extracts (5 µg/well), followed by ELISA with anti-p65 antibody. The competition experiment was done in a similar fashion but using plates coated with excess (20 pmol) NF-B consensus site mutant or wt oligonucleotides. The data represent the averages ± standard deviations of three experiments. (B) HMVEC-d cells and HFF untreated or pretreated with various concentrations of Bay11-7082 for 1 h were infected with KSHV (10 DNA copies/cell) for 30 min, and nuclear extracts were prepared and assayed for NF-B DNA binding activity. The percent nuclear translocation of NF-B-p65 inhibition by Bay11-7082 pretreatment was calculated with respect to the DNA binding activities in untreated KSHV-infected cells. (C) Histograms depicting the kinetics of percent inhibition of DNA binding activity in nuclear extracts from HMVEC-d cells and HFF pretreated with 10 µM Bay11-7082 for 1 h and then infected with KSHV (10 DNA copies/cell) for different times. The data represent the averages ± standard deviations of three experiments.

EMSA detects the increase in NF-B DNA binding activity in infected HMVEC-d and HFF cells.

View larger version (69K): [in this window] [in a new window]   FIG. 5. EMSA detection of KSHV-induced NF-B DNA binding activity. (A and B, top, lanes 1 to 7) HMVEC-d cells (A) and HFF (B), untreated or pretreated with 10 µM Bay11-7082 (1 h), were left uninfected or infected with KSHV (10 DNA copies/cell) for the indicated times. Nuclear extracts prepared from these cells were incubated with B-specific probe. The specificity of DNA-protein interaction was assessed by induction with TNF- (20 ng/ml) (lane 8), free probe (lane 9), normal probe (lane 11), or competitive EMSA using a 100x molar excess of unlabeled double-stranded oligonucleotide B probe (cold probe; lane 10). Nuclear extracts from HMVEC-d cells infected with 10 DNA copies/cell of live KSHV (C) or UV-KSHV (D) for 2 h, 8 h, and 24 h were analyzed by EMSA. Each EMSA is representative of at least three independent experiments. (A and B, bottom, lanes 1 to 11, and C and D, bottom) Oct1 probe used as loading control and specificity control to demonstrate the binding of NF-B to the specific probe. The arrows indicate the positions of the induced NF-B complexes.

KSHV induces a sustained level of NF-B induction during de novo infection of HMVEC-d and HFF cells. Early during infection of adherent target cells, KSHV induced the FAK, Src, PI 3-K, Rho-GTPase, PKC-, and ERK1/2 signal pathways, which were characterized by a rapid early response, followed by decline to the resting state within 2 to 4 h of observation (31, 44, 57, 58). Since we observed NF-B activation up to 120 min p.i. (Fig. 1) to determine the extent of NF-B induction and to compare it to other KSHV-induced signal cascades, infected HMVEC-d cells and HFF collected at different time points p.i. were analyzed for the phosphorylated forms of NF-B-p65, ERK1/2, AKT, and p38 MAPK. We observed a modest level of NF-B-p65 activation in the infected HMVEC-d cells at all time points tested (Fig. 6A). Phosphorylated p65 was detected as early as 10 min p.i., and sustained activation at a >2-fold increase over that of the uninfected cells was observed until 48 h p.i. (Fig. 6A, lanes 1 to 12), as well as at 72 h p.i. (data not shown). In contrast, there was a rapid increase in ERK1/2 phosphorylation, which peaked at 30 min p.i. with about 12.5-fold activation over that of the uninfected cells and decreased by 4 h p.i., followed by a second cycle of activation, which peaked at 24 h p.i. and returned to the basal level at 48 h p.i. (Fig. 6A).

View larger version (67K): [in this window] [in a new window]   FIG. 6. Sustained activation of NF-B during de novo infection of target cells by KSHV. Proteins prepared from HMVEC-d cells (A) and HFF (B) that were uninfected (UI) or infected with KSHV (10 DNA copies/cell) for 5 min, 10 min, 30 min, 1 h, 2 h, 4 h, 8 h, 12 h, 24 h, 36 h, 48 h, and 72 h were resolved by SDS-PAGE and transferred onto nitrocellulose membranes. Phosphorylated and total p65, ERK 1/2, AKT, and p38 MAPK proteins were detected with the respective antibodies. Each blot is representative of at least three independent experiments. The phosphorylation levels in the uninfected cells were considered to be 1 for comparison. For a control, cells were induced with TNF- for 20 min.

Previously, we did not observe the induction of lipopolysaccharide/stress-activated p38 MAPK during 60 min of KSHV infection in HMVEC-d, 293, or HFF cells (44). A recent study reported that p38 MAPK activation is essential for KSHV infection in human umbilical vein endothelial cells (49). Furthermore, the KSHV latency-associated gene product kaposin B (K12-B) has been shown to enhance the release of proinflammatory cytokines by activating the p38 MAPK-MAPK-associated protein kinase 2 (MK2) pathway and blocking cytokine mRNA decay by binding to MK2 (40). Cytokines that are secreted upon KSHV infection can act in an autocrine or paracrine fashion to activate p38 MAPK. Activation of many of these cytokines is known to be controlled by NF-B and p38 MAPK-MK2-kaposin B may play an important role in stabilizing the cytokine expression that is activated by NF-B. Hence, we examined the kinetics of p38 MAPK activation by KSHV. In agreement with our earlier results (44), there was only minimal activation of p38 MAPK at earlier time points (Fig. 6A, lanes 2 to 7). However, an appreciable level of p38 MAPK activation was observed at 8 h p.i. with about 2.6-fold activation over that of uninfected cells, peaking at 24 h p.i. with 3.8-fold induction and returning to basal level at 48 h p.i. (Fig. 6A, lanes 8 to 12). Equal loading of samples was demonstrated by detection of similar levels of total p65, AKT, p38, ERK2, and ß-actin throughout the observation period (Fig. 6A), which also clearly suggested that KSHV infection induces the phosphorylation of these proteins without affecting the total protein synthesis levels.

KSHV-infected HFF also displayed p65, ERK1/2, AKT, and p38 MAPK activation kinetics similar to that seen in HMVEC-d cells (Fig. 6B). There was modest steady-state activation of NF-KB-p65 at all time points, which peaked at 24 h p.i. (3.4-fold activation) and reached the basal level at 72 h p.i. We observed about 8-fold ERK1/2 phosphorylation as early as 5 min p.i., which peaked at 10 min at 9.2-fold and returned to basal level between 8 and 24 h p.i. (Fig. 6B). A second cycle of moderate ERK1/2 activation was seen at 24 to 48 h p.i. (Fig. 6B, lanes 10 to 12). The induction kinetics of phospho-AKT was similar to that of HMVEC-d cells but with two cycles of activation, the first cycle starting at 5 min p.i., peaking at 2 h p.i., and returning to basal level between 4 and 12 h p.i., with a second cycle of AKT activation seen at 24 h p.i. (2.2-fold activation), which was sustained at a moderate level until 72 h p.i. (Fig. 6B, lanes 2 to 13). Similar to HMVEC-d cells, minimal activation of p38 MAPK at earlier time points was observed in HFF (Fig. 6B, lanes 2 to 5), which started to increase at 2 h p.i., reached a maximum at 12 h p.i., and returned to basal levels at 72 h p.i. (Fig. 6B, lanes 6 to 13).

Taken together, these results demonstrated that KSHV infection induces a sustained level of NF-B during the 72-h period of observation, which is in contrast to the biphasic ERK1/2 and AKT activation and activation of p38 MAPK at later time points. These results also suggested that during primary infection of adherent target cells, KSHV must have evolved to differentially induce these signal molecules.

KSHV-induced NF-B does not play a role in entry of virus into target cells. KSHV entry overlaps with the induction of host cell preexisting signal pathways, such as FAK, Src, PI 3-K, Rho-GTPases, PKC-, and ERK1/2 (44, 57, 58). We have demonstrated the roles of FAK and PI 3-K in virus entry; the role of RhoA-GTPase in microtubule modulation, transport of capsid in the cytoplasm, and nuclear delivery; and a role for ERK1/2 in viral gene expression (31, 44, 45, 57). Target cells preincubated with the PI 3-K inhibitor LY294002 inhibited the internalization of KSHV DNA (58), whereas there was no significant reduction when cells were pretreated with the MEK/ERK inhibitor U0126 (57). To determine whether KSHV-induced NF-B plays a role in viral infection, we examined virus DNA internalization by quantitative real-time DNA PCR for the KSHV ORF 73 gene. Treatment of cells with three different concentrations of Bay11-7082 did not have any effect on KSHV DNA entry in both HMVEC-d cells and HFF (Fig. 7A). In contrast, preincubation of cells with 50 µM LY294002 reduced internalization by about 60% and 55% in HMVEC-d cells and HFF, respectively (Fig. 7A). These results demonstrated that KSHV-induced NF-B does not have a significant role in viral DNA internalization.

View larger version (59K): [in this window] [in a new window]   FIG. 7. Effect of Bay11-7082 on KSHV entry and KSHV ORF 73, ORF 50, K5, K8, and vIRF2 gene expression. (A) HMVEC-d cells and HFF, untreated or incubated with different concentrations of inhibitors for 1 h at 37°C, were infected with KSHV at 10 DNA copies/cell. For a control, cells were preincubated with 50 µM LY294002 (LY) for 1 h at 37°C before virus was added. After 2 h of incubation, the cells were washed twice with PBS to remove the unbound virus, treated with trypsin-EDTA for 5 min at 37°C to remove the bound but noninternalized virus, and washed, and total DNA was isolated. This was normalized, and the numbers of KSHV genome copies were estimated by real-time DNA PCR for ORF 73. The cycle threshold values were used to plot the standard graph and to calculate the relative copy numbers of viral DNA in the samples. The data are presented as the percent entry of KSHV DNA internalization obtained when the cells were incubated with virus alone. Each reaction was done in duplicate, and each bar represents the mean and standard deviation of three experiments. (B to F) Untreated HMVEC-d cells and HFF or cells pretreated with 10 µM Bay11-7082 for 1 h were infected with KSHV (10 DNA copies/cell) for 2 h, 8 h, and 24 h, and RNA was isolated and treated with DNase I for 1 h. A total of 250 ng of DNase-treated RNA was subjected to real-time RT-PCR with ORF 73, ORF 50, K5, K8, and vIRF2 gene-specific primers and TaqMan probes. Standard graphs generated using known concentrations of DNase-treated in vitro-transcribed ORF 73, ORF 50, K5, K8, and vIRF2 transcripts were used to calculate the relative copy numbers of viral transcripts and were normalized with GAPDH. Each reaction was done in duplicate, and each point represents the average ± standard deviation of three independent experiments. (B) Kinetics of ORF 73 and 50 gene expression in HMVEC-d cells. (C and D) Comparative kinetics of ORFs 73 and 50, K5, K8, and vIRF2 in HMVEC-d cells and HFF, respectively. (E and F) Histograms depicting the percent inhibition of KSHV ORF 73 and 50, K5, K8, and vIRF2 expression in the presence of Bay11-7082 in HMEVC-d cells and HFF, respectively.

Inhibition of NF-B blocks the expression of KSHV latent and lytic gene expression.

KSHV-induced NF-B plays a major role in the activation of AP-1 family transcription factors. The roles played by NF-B and AP-1 transcription factors independently in modulating KSHV latent and lytic gene expression in PEL cells are well documented (3, 64). However, there are no reports on the effects of NF-B inhibition on AP-1 transcription factors during de novo KSHV infection. Our studies suggested that NF-B activation is required for initiation of transcription of both latent and lytic genes in primary adherent target cells. To determine whether this is due to the ability of NF-B to modulate a variety of host transcription factors, we next examined the ability of KSHV infection to induce AP-1 transcription factors, which are known to be involved in KSHV latent and lytic gene expression (57).

Nuclear extracts from uninfected and infected HMVEC-d cells were assessed in an ELISA-based assay for the ability of the AP-1 transcription factors to bind to their respective wt DNA sequences. Since we observed NF-B activation very early during infection, nuclear extracts from HMVEC-d cells infected with KSHV for 15 min, 30 min, and 60 min were assayed for the AP-1 family of transcription factors. Infection of HMVEC-d cells with KSHV mediated a differential activation of AP-1 family transcription factors (Fig. 8). As shown in Fig. 8A, compared to uninfected cells, KSHV infection increased the activated forms of both Fos and the Jun family of transcription factors. A higher level of activation was observed for phospho-c-Jun, JunB, JunD, and cFos, while FosB, Fra1, and Fra2 transcription factors were moderately activated (Fig. 8A). Specificity experiments carried out with wt and mutated oligonucleotides demonstrated a significant reduction in the abilities of transcription factors to bind their respective target sequences by preincubation with wt oligonucleotides (data not shown).

View larger version (35K): [in this window] [in a new window]   FIG. 8. Effect of NF-B inhibition on AP-1 transcription factor activation. (A) Nuclear extracts prepared from uninfected HMVEC-d cells or HMVEC-d cells infected with KSHV for 15 min, 30 min, and 60 min were tested for the activation of AP-1-regulated transcription factors by incubating the nuclear extracts with the plate-immobilized oligonucleotides containing the AP-1 transcription factor-specific site, followed by ELISA with antibodies to the respective transcription factors. The histogram represents the activation levels of phospho-c-Jun, JunB, JunD, Fra1, Fra2, Fos-B, and c-Fos in the nuclear extracts from KSHV-infected HMVEC-d cells. The data represent the averages and standard deviations of three experiments, and the values shown here are after normalization with uninfected cells. (B) Histogram depicting the percent inhibition of DNA binding of AP-1 transcription factors in nuclear extracts from HMVEC-d cells pretreated with two different concentrations of Bay11-7082 and 10 µM U0126, followed by infection with KSHV. (C) Histogram depicting the percent activation of DNA binding of the phospho-c-Jun transcription factor in HMVEC-d nuclear extracts. Percent inhibition and percent activation were calculated with respect to the DNA binding activities in KSHV-infected HMVEC-d cells without Bay11-7082 pretreatment. The data represent the averages ± standard deviations of three experiments.

KSHV infection leads to NF-B-mediated up regulation of cytokines. KS lesion is an inflammatory angioproliferative lesion characterized by the presence of a variety of inflammatory cells, proinflammatory cytokines, and angiogenic factors in the lesions (16). Cultured KS lesion spindle cells require cytokines for their survival and proliferation (41), suggesting that cytokines probably act in both an autocrine and paracrine fashion. In our oligonucleotide array analysis of KSHV-infected HMVEC-d cells and HFF at 2 h and 4 h p.i., we observed the reprogramming of host transcriptional machinery regulating a variety of cellular processes, including apoptosis, cell cycle regulation, signaling, inflammatory response, and angiogenesis (46). Since NF-B is known to regulate the majority of these factors, we next analyzed the role of KSHV-induced NF-B in the regulation of the factors.

Conditioned media collected from KSHV-infected HMVEC-d cells at various time points p.i. were used to study the cytokine profile. Compared to the uninfected HMVEC-d cells, KSHV infection induced an increase in the secretion of the following categories of factors: (i) proinflammatory cytokines, such as interleukin 2 (IL-2), IL-3, IL-6, IL-8, IL-16, GRO, GRO, and gamma interferon (IFN-) (Fig. 9A and Table 1) ; (ii) anti-inflammatory cytokines, such as IL-4, IL-5, and IL-15 (Table 1); (iii) growth factors, such as platelet-derived growth factor (PDGF-BB), leptin, transforming growth factor ß1 (TGF-ß1), TGF-ß3, IGF-1, granulocyte-macrophage colony-stimulating factor (GM-CSF), G-CSF, M-CSF, and epidermal growth factor (EGF) (Fig. 9B and Table 1); (iv) angiogenic factors, like SDF-1, angiogenin, and SCF (Fig. 9C and Table 1); (v) chemokines, such as MCP-2, MCP-3, TARC, CKß 8-1, eotaxin, eotaxin 3, GCP-2, MIF, MIG, MDC, ENA-78, and BLC (Fig. 9D and Table 1); and (vi) tissue inhibitors of matrix metalloproteinases, such as TIMP-1 and TIMP-2 (Table 1).

Many of the KSHV infection-induced cytokines, growth factors, and angiogenic factors were inhibited by 10 µM Bay11-7082 pretreatment (Table 1). We observed twofold and fourfold reductions in IL-6 induction at 8 h and 24 h p.i., respectively. IL-3, IL-2, GRO, and IFN- showed greater than twofold reduction after Bay11-7082 pretreatment. Similarly, the observed remarkable increase in IGF-1, PDGF-BB, leptin, TGF-ß1, M-CSF, GM-CSF, and G-CSF growth factors after KSHV infection was also reduced by more than twofold with Bay11-7082. Among the chemokines, MCPs, MIG, MDC, MIP3, TARC, CKß 8-1, eotaxins, MIF, PARC, GCP-2, and BLC showed more than a threefold increase, and most of these chemokines were significantly reduced by NF-B inhibition. Appreciable changes were not detected in the growth factor binding protein and tissue inhibitors of matrix metalloproteinase induction with Bay11-7082 pretreatment, whereas anti-inflammatory cytokines, like IL-4, IL-5, IL-10, and IL-15, showed more than twofold reduction with 10 µM Bay11-7082 pretreatment, in comparison to the supernatant from untreated cells infected with KSHV. We also observed the up regulation of a variety of angiogenic factors, such as angiogenin, SCF, SDF-1, and VEGF, and they were also inhibited by Bay11-7082 pretreatment. Since the genes encoding these wide ranges of cytokines secreted upon KSHV infection possess NF-B binding sites in their promoter regions, their inhibition clearly demonstrated the role of KSHV-induced NF-B in the regulation of these factors.

	DISCUSSION

Top Abstract Introduction Materials and Methods Results Discussion References

 
During infection of target cells leading to a productive lytic replicative cycle or to the establishment of latency in certain target cells, herpesviruses need to overcome several obstacles, like apoptosis; host intrinsic, innate, and adaptive immune responses; and transcriptional restrictions. These obstacles need to be counteracted not only during the early time of infection, but also during the entire time of latent infection. Establishment of latent infection during in vitro infection of primary human endothelial cells or fibroblasts by KSHV provides an opportunity to analyze the various complex interactions between viral and host factors and the potential mechanism of establishment and maintenance of latent infection. Our previous studies have revealed that to overcome the obstacles early during infection, even before de novo viral gene transcription and expression, KSHV has adopted an optimum strategy of manipulating the host cells' preexisting signal pathways via interactions with cell surface receptors (Fig. 10). KSHV binds to the adherent target cell surface heparan sulfate molecule, to integrins, to the transporter CD98-xCT complex, and possibly to other molecules. This is followed by virus entry overlapping with the induction of preexisting host cell signal pathways, such as FAK, Src, PI 3-K, Rho-GTPases, PKC-, and ERK1/2. In this report, we provide multiple comprehensive evidence to suggest that, in addition to the signal cascades, and in contrast to the differential induction of ERK1/2 and p38 MAPK molecules, KSHV infection also induces NF-B very early during infection, which is sustained throughout the period of observation. Our studies give a snapshot of the complex events occurring early during infection of adherent target cells (Fig. 10). For clarity, we have summarized below these events and their potential implications on KSHV biology and pathogenesis.

View larger version (45K): [in this window] [in a new window]   FIG. 10. Schematic representation depicting the early and late induction phases of NF-B during in vitro KSHV infection of HMVEC-d cells and their potential roles in transcription factor regulation, establishment and maintenance of KSHV infection, and cytokine secretion. In the early phase of NF-B induction (blue arrows), virus binding and entry lead to signal pathway induction, such as FAK, Src, PI 3-K, AKT, PKC-, MAPK-ERK1/2, and NF-B signal molecules. Activated NF-B translocates into the nucleus, which coincides with viral-DNA entry into the infected-cell nuclei, concurrent transient expression of limited viral lytic genes, and persistent latent gene expression. Overlapping with these events, a limited number of cytokines and growth factors are induced, which is initiated by transcription factors, like AP-1 (induced by ERK1/2 and NF-B). Early activation of NF-B and ERK1/2 also leads to the activation and release of NF-B-inducible host factors, which act in autocrine and paracrine fashions on the infected, as well as neighboring, cells. The autocrine action of these factors, along with viral gene expression, probably contributes to the second, or late, phase of signal pathway activation (red arrows), including sustained NF-B activation and phosphorylation of p38 MAPK, ERK1/2, and AKT required for the maintenance of latency. The blue and red arrows together indicate pathways induced during both early and late phases of KSHV infection.

Role of NF-B in KSHV gene expression during endothelial cell infection.

We have previously demonstrated that KSHV-induced ERK1/2 play roles in the regulation of ORF 50 and ORF 73 gene expression, probably in the initiation of their expression. KSHV-induced NF-B also appears to influence viral gene expression, which could be by direct interactions with the viral gene transcription initiation region or by indirect methods, such as the activation of host transcription factors and/or host genes, which in turn play roles in viral gene expression. Examination of ORF 50 and ORF 73 gene promoter regions show that only the ORF 50 gene, and not the ORF 73 gene, possesses NF-B binding sites in its promoter region (35), suggesting that NF-B could directly influence the transcriptional activation of the ORF 50 gene. KSHV latency-associated vFLIP has been shown to persistently activate NF-B by interacting with the IKK-IKKß-IKK complex, and this has been taken as evidence for NF-B's role in the maintenance of KSHV latency in PEL cells (13). However, how NF-B regulates the latent genes is not known. ORF 50 (RTA) is believed to contribute to the establishment of latency through activation of LANA-1 expression in the early stages of infection (36). LANA-1 has been shown to physically interact with RBPJ and to bind to the RTA promoter and block the activation of RTA (34). Thus, there exists a feedback loop through which LANA-1 and RTA possibly regulate each other. Even though there is no NF-B binding site in the ORF 73 promoter, since the impact of blocking RTA could be manifested at various levels, the inhibition of ORF 73 gene expression by NF-B inhibition could also be due to the blocking of RTA expression by Bay11-7082 pretreatment.

KSHV vIRF2 and K8 are expressed early during infection of HMVEC-d cells, and Bay11-7082 pretreatment inhibited the expression of these genes. Since RTA (ORF 50) protein is known to control the transcription of both K8 and vIRF2 by binding to the RTA response element present in the promoter regions of these lytic genes, K8 and vIRF2 inhibition upon NF-B blockade could be attributed directly to RTA inhibition. The regulation of the lytic K5 gene is known to be independent of RTA (47) and was not influenced by ERK1/2 early during infection (27, 57). Since the K5 gene also does not have an NF-B binding site, inhibition of the K5 gene observed after Bay11-7082 pretreatment could also be an indirect effect of various transcription factors under the control of NF-B. Our results are in agreement with the studies by Keller et al. (27), who did not observe any increase in lytic gene activation in PEL cells after Bay11-7082 treatment.

KSHV induced NF-B and AP-1 activation. Activation of any viral or cellular gene is not controlled by a single transcription factor but by interplay between various transcription factors, and one transcription factor could control the expression of others. It is interesting that the LANA-1 and K5 genes possess several transcription factor binding motifs, including AP-1, SP1, cMyc, and c-Jun. Previous reports demonstrated that AP-1 activity may be critical for very early activation of the RTA and K8 promoters during the lytic cycle (75), and our studies have shown that ERK1/2, via the activation of AP-1 and other MAPK-related transcription factors, play important roles in the activation of the LANA-1 and RTA genes (57). Inhibition of ERK1/2 using the MEK inhibitor U0126 blocked RTA, LANA-1, K8, and vIRF2 gene expression but had minimal effect on K5 (57), whereas Bay11-7082 pretreatment inhibited all five of the genes. These studies demonstrate that KSHV gene expression is controlled by the regulation of multiple transcription factors, and inhibiting ERK1/2 probably inhibited only the factors downstream of ERK1/2. In contrast, Bay11-7082 pr